Managing Partner, Chief Growth & Innovation Officer at REMEDY EDGE™
📍 Mountain Lakes, New Jersey, United States
Eileen Yaralian is the Managing Partner and Chief Growth & Innovation Officer at REMEDY EDGE™, bringing over 20 years of experience in pharmaceutical, biotech, and medical device marketing strategy. She is a recognized expert in rare disease and oncology, with a degree from the University of Pennsylvania.
She is the Dean of Omnicom Health Groups Rare University and the Rare Collective.
They can sound friendly and charming but can quickly change gears to become inquisitive and probing. They are generally good communicators and can be hard to convince. They often ask many questions and rely heavily on information and documentation.
Priorities
Topics Eileen cares about
Rare Disease Strategy
An expert in rare disease marketing, she also serves as Dean for Omnicom Health Group's Rare University, demonstrating deep leadership and knowledge in this specialized field.
Agency Growth
As Chief Growth & Innovation Officer, her professional focus is on leading new business opportunities and driving strategic expansion for her agency.
Influence (I) reflects the degree to which a person prefers to work by influencing or persuading others. Those scoring high tend to be people oriented, motivated by social recognition and building relationships.
More profiles
Discover additional public profiles from our index.